Muestra la distribución de la producción WoS, Scopus y SciELO del autor.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
| Firmas del autor | |
| Nombre | MARTINEZ, MARIPAZ |
| Género | - |
| Área Principal WOS | Medicine, General & Internal; Neurosciences; Psychiatry; |
| Afiliación Principal | Clínica Las Condes |
| ORCID
|
0000-0002-8127-7620 |
Publicaciones en Chile
Citas Totales
Afiliaciones Chilenas
| WOS | #Pub |
|---|---|
| Medicine, General & Internal | 1 |
| Neurosciences | 1 |
| Psychiatry | 1 |
| Respiratory System | 1 |
| Immunology | 1 |
| Orthopedics | 1 |
| Clinical Neurology | 1 |
| Scopus | #Pub |
|---|---|
| Neurology (Clinical) | 2 |
| Surgery | 1 |
| Medicine (All) | 1 |
| Orthopedics And Sports Medicine | 1 |
| Biological Psychiatry | 1 |
| SciELO | #Pub |
|---|---|
| Health Sciences | 1 |
| Año | Firma | Institución (Incites asoc.) | H Index | Average Percentile | Impact Citation | Impact Relative World | Impact Journal Normalized Citation | Impact Category Normalized Citation | Percentage Cited | Percentage Top 1 | Percentage Top 10 | Percentage Journal Q1 | Percentage Journal Q2 | Percentage Journal Q3 | Percentage Journal Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | Martinez, Maripaz | Clinica Las Condes | 1.0 | 55.7 | 3.0 | 0.3 | 5.7 | 0.5 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Palabra Clave | #Pub |
|---|---|
| pathogenesis | 1 |
| latin america | 1 |
| lumbar region | 1 |
| macrophage activation | 1 |
| management | 1 |
| messenger-rna | 1 |
| microrna | 1 |
| microrna family | 1 |
| micrornas | 1 |
| microsatellite instability | 1 |
| mir-378a-3p | 1 |
| mucosal | 1 |
| multicenter trial | 1 |
| mutation | 1 |
| nusinersen | 1 |
| outpatients | 1 |
| island methylator phenotype | 1 |
| ppargc1b | 1 |
| prognostic impact | 1 |
| randomized | 1 |
| regulator | 1 |
| scale | 1 |
| sham control | 1 |
| smn1 | 1 |
| spinal fusion | 1 |
| spinal muscular atrophy | 1 |
| spinal-fusion | 1 |
| standard of care | 1 |
| surgery | 1 |
| survival | 1 |
| therapy | 1 |
| ulcerative colitis | 1 |
| covid-19 | 1 |
| alarmin | 1 |
| ambulatory care | 1 |
| arthrodesis | 1 |
| barrier function | 1 |
| bowel-disease | 1 |
| braf | 1 |
| carcinogenesis | 1 |
| children | 1 |
| chromosomal instability | 1 |
| cin | 1 |
| classification | 1 |
| clinical trial | 1 |
| closed-suction drainage | 1 |
| colon-cancer | 1 |
| colorectal neoplasms | 1 |
| adolescents | 1 |
| cpg island | 1 |
| demography | 1 |
| diagnosis | 1 |
| dna | 1 |
| drain | 1 |
| epidemiology | 1 |
| follow-up studies | 1 |
| genetics | 1 |
| genomic medicine | 1 |
| growth | 1 |
| hospitalization | 1 |
| ibd | 1 |
| il-33 | 1 |
| increased expression | 1 |